Cargando…

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance

PURPOSE: In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients’ perspectives regarding less intensive surveillance in case of a low risk of recurrence. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankersmid, Jet W., Drossaert, Constance H. C., van Riet, Yvonne E. A., Strobbe, Luc J. A., Siesling, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442247/
https://www.ncbi.nlm.nih.gov/pubmed/35122224
http://dx.doi.org/10.1007/s11764-022-01178-z
_version_ 1785093550470332416
author Ankersmid, Jet W.
Drossaert, Constance H. C.
van Riet, Yvonne E. A.
Strobbe, Luc J. A.
Siesling, Sabine
author_facet Ankersmid, Jet W.
Drossaert, Constance H. C.
van Riet, Yvonne E. A.
Strobbe, Luc J. A.
Siesling, Sabine
author_sort Ankersmid, Jet W.
collection PubMed
description PURPOSE: In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients’ perspectives regarding less intensive surveillance in case of a low risk of recurrence. METHODS: We conducted semi-structured interviews with 22 women in the post-treatment surveillance trajectory in seven Dutch teaching hospitals. RESULTS: Although the majority of participants indicated a desire for shared decision-making (SDM) about post-treatment surveillance, participants experienced no SDM. Information provision was often suboptimal and unstructured. Participants were open for using risk information in decision-making, but hesitant towards less intensive surveillance. Perceived advantages of less intensive surveillance were: less distressing moments, leaving the patient role behind, and lower burden. Disadvantages were: fewer moments for reassurance, fear of missing recurrences, and a higher threshold for aftercare for side effects. CONCLUSIONS: SDM about post-treatment surveillance is desirable. Although women are hesitant about less intensive surveillance, they are open to the use of personalised risk assessment for recurrences in decision-making about surveillance. IMPLICATIONS FOR CANCER SURVIVORS: To facilitate SDM about post-treatment surveillance, the timing and content of information provision should be improved. Risk information should be provided in an accessible and understandable way. Moreover, fear of cancer recurrence and other personal considerations should be addressed in the process of SDM.
format Online
Article
Text
id pubmed-10442247
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104422472023-08-23 Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance Ankersmid, Jet W. Drossaert, Constance H. C. van Riet, Yvonne E. A. Strobbe, Luc J. A. Siesling, Sabine J Cancer Surviv Article PURPOSE: In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients’ perspectives regarding less intensive surveillance in case of a low risk of recurrence. METHODS: We conducted semi-structured interviews with 22 women in the post-treatment surveillance trajectory in seven Dutch teaching hospitals. RESULTS: Although the majority of participants indicated a desire for shared decision-making (SDM) about post-treatment surveillance, participants experienced no SDM. Information provision was often suboptimal and unstructured. Participants were open for using risk information in decision-making, but hesitant towards less intensive surveillance. Perceived advantages of less intensive surveillance were: less distressing moments, leaving the patient role behind, and lower burden. Disadvantages were: fewer moments for reassurance, fear of missing recurrences, and a higher threshold for aftercare for side effects. CONCLUSIONS: SDM about post-treatment surveillance is desirable. Although women are hesitant about less intensive surveillance, they are open to the use of personalised risk assessment for recurrences in decision-making about surveillance. IMPLICATIONS FOR CANCER SURVIVORS: To facilitate SDM about post-treatment surveillance, the timing and content of information provision should be improved. Risk information should be provided in an accessible and understandable way. Moreover, fear of cancer recurrence and other personal considerations should be addressed in the process of SDM. Springer US 2022-02-04 2023 /pmc/articles/PMC10442247/ /pubmed/35122224 http://dx.doi.org/10.1007/s11764-022-01178-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ankersmid, Jet W.
Drossaert, Constance H. C.
van Riet, Yvonne E. A.
Strobbe, Luc J. A.
Siesling, Sabine
Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title_full Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title_fullStr Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title_full_unstemmed Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title_short Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
title_sort needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442247/
https://www.ncbi.nlm.nih.gov/pubmed/35122224
http://dx.doi.org/10.1007/s11764-022-01178-z
work_keys_str_mv AT ankersmidjetw needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance
AT drossaertconstancehc needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance
AT vanrietyvonneea needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance
AT strobbelucja needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance
AT sieslingsabine needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance
AT needsandpreferencesofbreastcancersurvivorsregardingoutcomebasedshareddecisionmakingaboutpersonalisedposttreatmentsurveillance